Menu
Home
Log in / Register
 
Home arrow Health arrow Bariatric surgery patients: a nutritional guide
Source

Food Sources of Folate

Green leafy vegetables are rich sources of folate, providing the basis for its name. Citrus fruits and legumes are also excellent sources.

Leaf lettuce 1 cup 40 |ig

Kale, chopped 1 cup 19 |ig

Spinach, cooked 1 cup 263 |ig

Orange, raw 1 47 |ig

Chickpeas, cooked 1/2 cup 141 |ig

References

  • 1. Plaisted CS, Istfan NW. Metabolic abnormalities of obesity. Obesity Pathophysiology Psychology and Treatment. In: Blackburn GL, Kanders BS, eds. New York, NY: Chapman & Hall 1994.
  • 2. Tailleux A, Rouskas K, Pattou F, et al. Bariatric surgery, lipoprotein metabolism and cardiovascular risk. Curr Opin Lipidol2015;26:317-324.
  • 3. Kaplan NH. Hypertension and hyperinsulinemia. Prim Care 1991;18:483.
  • 4. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595.
  • 5. Feingold KR, Grunfeld C. Obesity and dyslipidemia. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., eds. Endotext [Internet]. South Dartmouth, MA: MDText.com, Inc.; 2000. Available at: http://www .ncbi.nlm.nih.gov/books/NBK305895/.
  • 6. Padilla N, Maraninchi M, Beliard S, et al. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans. Arterioscler Thromb Vasc Biol2014;34:2330-2337.
  • 7. Batsis JA, Miranda WR, Prasad C, et al. Effect of bariatric surgery on cardiovascular risk in elderly patients: A population-based study. Geriatr Gerontol Int 2015;16:618-624.
  • 8. Domienik-Karlowicz J, Dzikowska-Diduch O, Lisik W, et al. Shortterm cardiometabolic risk reduction after bariatric surgery. Hellanic J Cardiol 2015;56:61-65.
  • 9. Corcellas R, Daigle CR, Schauer PR. Management of endocrine diseases: Metabolic effects of bariatric surgery. Eur J Endocrinol 2016;174:R19-28.
  • 10. Morshed G, Fathy SM. Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women. Wideochir Inne Tech Maloinwazyjne 2016;10:521-526.
  • 11. McLellan KCP, Wyne K, Villagomez ET, et al. Pharmacologic treatment of prediabetes. Pract Diabetel. 2014 May/June;33:6-11.
  • 12. Bell DSH. Metformin: A lifesaver for those with and without diabetes. PracticalDiabetology. 2016 March/April;35:16-17.
  • 13. Guilliford MC, Booth HP, Reddy M, et al. Effect of contemporary bariatric surgery procedures on Type 2 diabetes remission—A population- based matched cohort study. Obes Surg 2016 Feb 27. [Epub ahead of print.]
  • 14. Omotosho P, Mor A, Shantavasinkul PC, et al. Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. Surg Endosc 2016;28. [Epub ahead of print.]
  • 15. deOliveira LF, Tisott CG, Silvano DM, et al. Glycemic behavior in 48 hours postoperative period of patients with type 2 diabetes mel- litus and nondiabetic submitted to bariatric surgery. Arg Bras Cir Dig 2015;28:26-30.
  • 16. Hansen M, Lund MT, Jorgensen AL, et al. The effects of diet-and RYGB-induced weight loss on insulin sensitivity in obese oatients with and without Type 2 diabetes. Acta Diabetol2015;53:423-432.
  • 17. Yaska JP, vanRoon EN, de Boer A, et al. Remission of Type 2 diabetes mellitus in patients after different types of bariatric surgery: A population-based cohort study in the United Kingdom. JAMA Surgery 2015 Dec 1;150(12):1126-1133.
  • 18. Pappachan JM, Viswanath AK. Metabolic surgery: A paradigm shift in Type 2 diabetes management. World J Diabetes 2015 Dec 1;150(12)1126-1133.
  • 19. Warren JA, Ewing JA, Hale AL, et al. Cost-effectiveness of bariatric surgery: Increasing the economic viability of the most effective treatment for Type II Diabetes Mellitus. Am Surg2015;81:807-811.
  • 20. Argyropoulos G. Bariatric surgery: Prevalence, predictors, and mechanisms of diabetes remission. Curr Diab Rep 2015;15:15.
  • 21. Cummings DE. Surgery to treat diabetes vs lifestyle interventions. Obesity Week 2013.
  • 22. Fanin A, Benetti A, Ceriani V, et al. Bariatric surgery versus medications in the treatment of Type 2 diabetes. Minerva Endocrinol 2015;40:297-306.
  • 23. Hsu CC, Almulaifi A, Chen JC, et al. Effect of bariatric surgery vs medical treatment on Type 2 diabetes on patients with body mass index lower than 35: Five-year outcomes. JAMA Surgery 2015 Dec 1;150(12):1117-1124.
  • 24. Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab 2015 Sept-Oct;19(5):563-576.
  • 25. Chen Y, Corsino L, Shantavasinkul PC, et al. Gastric bypass leads to long-term remission or improvement of type 2 diabetes and significant decrease of microvascular and macrovascular complications. Ann Surg 2016;263(6):1138-1142.
  • 26. Brethauer SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with Type 2 diabetes mellitus. Ann Surg 2013;258: 628-637.
  • 27. Panunji S, Carlsson L, De Gaetano A, et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care 2016;39:166-174.
  • 28. Grams J, Garvey WT. Weight loss and the prevention and treatment of Type 2 diabetes using lifestyle therapy, pharmacotherapy and bariatric surgery: Mechanisms of action. Curr Obes Rep 2015;4:287-302.
  • 29. Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment and prevention of the disease of obesity: Reflections form a diabetes care editors’ expert forum. Diabetes Care 2015;38:1567-1582.
  • 30. Khanna V, Malin SK, Bena J, et al. Adults with long-duration Type 2 diabetes have blunted glycemic and B cell function improvement after bariatric surgery. Obesity 2015;23:523-256.
  • 31. Jukubowicz D, Wainstein J, Ahren B, et al. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with Type 2 diabetes: A randomized clinical trial. Diabetes Care 2015;38:1820-1826.
  • 32. Seaman AM. Bariatric surgery edges out lifestyle changes for Type 2 diabetes. JAMA Surgery 2015.
  • 33. Courcoulas AP, Belle BH, Neiberg RH, et al. Three year outcomes of bariatric surgery vs lifestyle intervention for Type 2 diabetes mellitus treatment. JAMA Surgery 2015;150:931-940.
  • 34. Dogan K, Betzel B, Homan J, et al. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslip- idemia in morbidly obese patients. Obes Surg2014;24:1835-1842.
  • 35. Xiong SW, Cao J, Liu XM, et al. Effect of modified Roux-en-Y gastric bypass surgery on GLP-1, GIP in patients with Type 2 diabetes mellitus. Gastroenterol Res Pract 2015;62:5196.
  • 36. Golomb J, Bendavid M, Glass A, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy. JAMA Surgery 2015;150:1051-1057.
  • 37. Ashrafian H, Harling L, Toma T, et al. Type 1 diabetes mellitus and bariatric surgery: A systemic review and meta-analysis. Obes Surg 2015 Dec 22.
  • 38. Mahawar KK, De Alwis N, Carr WR, et al. Bariatric surgery in Type 1 diabetes mellitus: A systemic review. Obes Surg 2016;26:196-204.
  • 39. Markova M et al. Better blood glucose control found with high-protein diets from plant, animal sources. Endocrine Today, Nov 2015.
  • 40. Martinez-Gonzalez MA, de la Fuente-Arrillaga C, Nunez-Cordoba JM, et al. Adherence to Mediterranean diet and risk of developing diabetes: Prospective cohort study. BMJ 2005;336:1348-1351.
  • 41. Lacoppidan SA, Kyra C, Loft S, et al. Adherence to a healthy nordic food index is associated with lower risk of Type 2 diabetes—The Danish Diet, Cancer and Health Cohort Study. Nutrients 2015;7:8633-8644.
  • 42. Saudi J. The effect of bariatric surgeries on nonalcoholic fatty liver disease. Gastroenterol 2014 Sept-Oct; 20(5): 270-278.
  • 43. Clark JM, Alkhuraishi AR, Solga SF, et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 2005;13:1180-1186.
  • 44. Feijo SG, Lima JM, Oliveira MA, et al. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: Prevalence and associated risk factors. Acta Cir Bras 2013;28:788-793.
  • 45. Xanthakos SA, Jenkins TM, Kleiner DE, et al. High prevalence of non alcoholic fatty liver disease in adolescents undergoing bariatric surgery. Gastroenterology 2015;149:623-634.
  • 46. Sasaki A, Nitta H, Otsuka K, et al. Bariatric surgery and non-alcoholic fatty liver disease: Current and potential future treatments. Front Endocrinol 2014;27:164.
  • 47. Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis 2010;28:274-279.
  • 48. deAlmeida SR, Rocha PR, Sanches MD, et al. Roux-en-Y bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg 2006;16:270-278.
  • 49. Liu X, Lazenby AJ, Clements RH, et al. Resolution of nonalcoholic steatohepatitis after gastric bypass surgery. Obes Surg 2007;17:486-492.
  • 50. Cheron RG, Kaplan MM, Larsen PR. Physiological and pharmacological influences on thyroxine to 3,5,3-triiodothyronine conversion and nuclear 3,5,3-triiodothyronine binding in rat anterior pituitary. J Clin Invest 1979;64:1402-1414.
  • 51. Araujo RL, Andrade BM, da Silva ML, et al. Tissue specific deiodinase regulation during food restriction and low replacement dose of leptin in rats. Am J Physiol Endocrinol Metab 2009;296:E1157-1163.
  • 52. Leibel RL, Jirsch J. Diminished energy requirements in reduced-obese patients. Metabolism 1984;33:164-170.
  • 53. Wilson D. Evidence-Based Approach to Restoring Thyroid Health. Lady Lake, FL: Muskeegee Medical Publishing, 2014.
  • 54. Fontana L, Klein S, Holloszy JO, et al. Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J Clin Endocrinol Metab 2006;91:3232-3235.
  • 55. Silva JE, Larsen PR. Hormonal regulation iodothyronine 5’-deiodinase in rat brown adipose tissue. Am J Physiol 251;E639-E643.
  • 56. Croxson MS, Ibbertson HK. Low serum triiodothyronine (T3) and hypothyroidism. J Clin Endocrinol Metab 1977;44:167-174.
  • 57. Katzeff HL, Selgrad C. Impaired peripheral thyroid hormone metabolism in genetic obesity. Endocrinology 1993;132:989-995.
  • 58. Islam S., Yesmire S, Khan SA, et al. A comparative study of thyroid hormone levels in diabetic and non-diabetic patients. SE Asian J Trop Med Public Health 2008;39:913-916.
  • 59. Benvenga S, Cahnmann HJ, Robbins J. Characterization of thyroid hormone binding to apolipoprotein E: Localization of the binding site in the exon 3-coded domain. Endocrinology 1993;133:1300-1305.
  • 60. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012;42:252-265.
  • 61. McGrogan A, Seaman HE, Wright JW, et al. The incidence of autoimmune thyroid disease: A systematic review of the literature. Clin Endocrinol 2008;69:687-696.
  • 62. Delange F. The disorders induced by iodine deficiency. Thyroid 1994;4:107-128.
  • 63. Pizzulli A, Ranjbar A. Selenium deficiency and hypothyroidism: A new etiology in the differential diagnosis of hypothyroidism in children. Biol Trace Elem Res 2000;77:199-208.
  • 64. Watts DL. The nutritional relationship of the thyroid. J Orthomol Med 1989;4:165-169.
  • 65. Lips MA, Pyl H, van Klinken JB, et al. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur J Endocrinol 2013 Aug 28;169(3):339-347.
  • 66. MacCuish A, Razvi S, Syed AA. Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity. Clin Obes 2012 Feb;2(1-2):25-28.
  • 67. Alagna S, Cossu ML, Masala A, et al. Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery. Eat Weight Dis 2003 Jun;8(2):95-99.
  • 68. Janssen IM, Homan J, Schijns W, et al. Subclinical hypothyroidism and its relation to obesity in patients before and after Roux-en Y gastric bypass. Surg Obes Relat Dis 2015 Nov-Dec;11(6):1257-63.
  • 69. Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 2007 Nov-Dec;3(6):631-35.
  • 70. Fazylov R, Soto E, Cohen S, et al. Laaparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism. Obes Surg 2008 Jun;18(6):644-647.
  • 71. Gkotsina M, Michalaki M, Mamali I, et al. Improved levothroxine pharmacokinetics after bariatric surgery. Thyroid 2013 Apr; 23(4):414-419.
  • 72. Vita R, Fallahi P, Antonelli A, et al. The administration of thyroxine as a soft gel capsule or liquid solution. Expert Opin Drug Deliv 2014 Jul; 11(7):1103-1111.
  • 73. Michalaki M, Volonakis S, Mamali I, et al. Dietary iodine absorption is not influenced by malabsorptive bariatric surgery. Obes Surg 2014 Nov;24(11):1921-1925.
  • 74. Abu-Ghanem Y, Inbar R, Tyomkin V, et al. Effect of sleeve gastrectomy on thyroid hormone levels. Obes Surg2015 Mar;25(3):452-456.
  • 75. Dunaif A, Chang J, Franks S, et al eds. In: Contemporary Endocrinology. Totowa, NJ: Humana Press, 2008, p. 217.
  • 76. Davies N. Polycystic ovary syndrome. Diabetes Self Management Feb 2016.
  • 77. Thatcher SS. PCOS the Hidden Epidemic. Indianapolis, IN: Perspectives Press, 2000, p. 156.
  • 78. Escobar-Morreale HF. Surgical management of metabolic dysfunction in PCOS. Steroids 2012 Mar 10;77(4):312-316.
  • 79. Ollila MM, Piltonen T, Puukka, et al. Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: Prospective cohort study. J Clin Endocrinol Metab 2016;101:739-747.
  • 80. Messinis IE, Messini CI, Anifandis G, et al. Polycystic ovaries and obesity. Best Pract Res Clin Obstet Gynaecol2015 May;29(4):479-488.
  • 81. Caserta D, Adducchio G, Picchia S, et al. Metabolic syndrome and polycystic ovary syndrome: An intriguing relationship. Gynecol Endocrinol 2014 Jun;30(6):397-402.
  • 82. Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis 2014 Sept-Oct;10(5):787-791.
  • 83. Schiavo L, Scalera G, Barbarisi A. Sleeve gastrectomy to treat con- commitant polycystic ovary syndrome, insulin and leptin resistance in a 27-year morbidly obese woman unresponsive to insulin-sensitizing drugs: A 3-year follow-up. Int JSurg Case Rep 2015 Oct 21;17:36-38.
  • 84. Skubleny D, Switzer NJ, Gill RS, et al. The impact of bariatric surgery on polycystic ovary syndrome: A systematic review and meta-analysis. Obes Surg 2016 Jan;26(1):169-176.
  • 85. Barber TM, Dimitriadis GK, Andreou A, et al. Polycystic ovary syndrome: Insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2015 Dec;15(Suppl 6):S72-S76.
  • 86. Turkmen S, Andreen L, Cengiz Y. Effects of Roux-en-Y gastric bypass surgery on eating behavior and allopregnanolone levels in obese women with polycystic ovary syndrome. Gynecol Endocrinol 2015 Apr;31(4):301-305.
  • 87. Moran LJ, Brinkworth GD, Norman RJ. Dietary therapy in polycystic ovary syndrome. Semin ReprodMed2008 Jan;26:85-92.
  • 88. Subbiah MT. Nutrigenetics and nutraceuticals: The next wave riding on personalized medicine. TranslRes 2007 Feb;149(2):55-61.
  • 89. Frankel F. The Methylation Miracle. New York, NY: St. Martin’s Press, 1999.
  • 90. Miller R, Bowers B. MethylGenetic Nutrition Breaking the Genetic Code. Philadelphia, PA, Nov 7-8, 2015.
  • 91. Yin RX, Wu DF, Aung LH, et al. Several lipid-related gene polymorphisms interact with overweight/obesity to moderate blood pressure levels. Int J Mol Sci 2012;13(9):2062-2081.
  • 92. Yin RX, Wu DF, Miao L, et al. Several genetic polymorphisms interact with overweight/obesity in influence serum lipid levels. Cardiovasc Diabetol 2012 Oct 8; 11:123.
  • 93. Lewis SJ, Lawlor DA, Nordestgaard BG, et al. The methylenetetrahy- drofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts. Eur J Endocrinol2008 Jul;159(1):35-40.
  • 94. Alghasham A, Settin AA, Ali A, et al. Association of MTHFR C677T and A1298C gene polymorphisms with hypertension. Int J Health Sci 2012 Jan;6(1):3-11.
  • 95. Koo HS, Lee HS, Hong YM. Methylenetetrahydrofolate reductase TT genotype as a predictor of cardiovascular risk in hypertensive adolescents. Pediatr Cardiol2008 Jan;29(1):136-141.
  • 96. Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and associated diseases. Eur J Med Genet 2015 Jan;58(1):1-10.
  • 97. Lunegova OS, Kerimkulova AS, Turdakmatov NB, et al. Association of C677T gene polymorphism of methylenetetra- hydrofolate reductase with insulin resistance among Kirghizes. Kardiologiia 2011;51:58-62.
  • 98. Tavakkoly Bazzaz J, Shojapoor M, et al. Methlenetetrahydrofolate reductase gene polymorphism in diabetes and obesity. Mol Biol Rep 2010 Jan;37(1):105-109.
  • 99. Frelut ML, Nicolas JP, Guilland JC, et al. Methylenetetrathydrofolate reductase 677 C^T polymorphism: A link between birth weight and insulin resistance in obese adolescents. Int JPediatr Obes. 2011;6:e312-e317.
  • 100. DiRenzo L, Marsella LT, Sarlo F, et al. C677T gene polymorphism of MTHFR and metabolic syndrome: Response to dietary intervention. J Transl Med 2014 Nov 29;12:329.
  • 101. Yarandi SS, Griffith DP, Sharma R, et al. Optic neuropathy, myelopathy, anemia, and neutropenia casued by acquired copper deficiency after gastric bypass surgery. J Clin Gastroenterol2014 Nov-Dec;48(10):862-865.
  • 102. Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofo- late are not the same thing. Xenobiotica 2014 May;44(5):480-8.
 
Source
Found a mistake? Please highlight the word and press Shift + Enter  
< Prev   CONTENTS   Next >
 
Subjects
Accounting
Business & Finance
Communication
Computer Science
Economics
Education
Engineering
Environment
Geography
Health
History
Language & Literature
Law
Management
Marketing
Mathematics
Political science
Philosophy
Psychology
Religion
Sociology
Travel